Werbung
Werbung
SYRE
Spyre Therapeutics, Inc. Common Stock
30.62
USDGesponsert
+0.48
+1.59%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
30.98
+0.37
+1.20%
SYRE Ergebnisberichte
Positives Überraschungsverhältnis
SYRE übertreffen die 17 der letzten 39Schätzungen.
44%
Nächster Bericht
Datum des nächsten Berichts
25. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.78
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/+420.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-3.70%
Spyre Therapeutics, Inc. Common Stock earnings per share and revenue
On 04. Nov. 2025, SYRE reported earnings of -0.15 USD per share (EPS) for Q3 25, beating the estimate of -0.76 USD, resulting in a 80.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.57% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of -0.78 USD, with revenue projected to reach -- USD, implying an increase of 420.00% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
What were Spyre Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Spyre Therapeutics, Inc. Common Stock reported EPS of -$0.15, beating estimates by 80.3%, and revenue of $0.00, 0% as expectations.
How did the market react to Spyre Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -0.57%, changed from $22.98 before the earnings release to $22.85 the day after.
When is Spyre Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 25. Feb. 2026.
What are the forecasts for Spyre Therapeutics, Inc. Common Stock's next earnings report?
Based on 15
analysts, Spyre Therapeutics, Inc. Common Stock is expected to report EPS of -$0.78 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung